A patient taking lorazepam (Ativan) 1 mg twice daily wants to switch to diazepam (Valium); what dose is appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benzodiazepine Conversion: Lorazepam to Diazepam

Switch from lorazepam (Ativan) 1 mg twice daily to diazepam (Valium) 5 mg twice daily using a 1:5 conversion ratio.

Conversion Calculation

The standard benzodiazepine equivalency ratio is 1 mg lorazepam = 5 mg diazepam 1.

  • Current dose: Lorazepam 1 mg BID = 2 mg total daily
  • Equivalent diazepam dose: 2 mg × 5 = 10 mg total daily
  • Recommended dosing: Diazepam 5 mg twice daily

This conversion is supported by the FDA-approved dosing for Valium, which indicates 2-10 mg given 2-4 times daily for anxiety management 1.

Critical Implementation Strategy

Do NOT abruptly switch between benzodiazepines. A case report demonstrates that direct switching from lorazepam to diazepam without cross-titration can precipitate severe withdrawal symptoms, including delirium, even at equivalent doses 2. This occurs because diazepam's long-acting metabolite (N-desmethyl-diazepam) requires time to accumulate to therapeutic levels.

Recommended Cross-Titration Approach:

  1. Day 1-3: Start diazepam 5 mg BID while continuing lorazepam 1 mg BID
  2. Day 4-6: Reduce lorazepam to 0.5 mg BID, continue diazepam 5 mg BID
  3. Day 7-9: Reduce lorazepam to 0.5 mg daily, continue diazepam 5 mg BID
  4. Day 10+: Discontinue lorazepam, continue diazepam 5 mg BID alone

This gradual cross-titration allows N-desmethyl-diazepam to reach steady-state levels (takes 5-7 days) before fully discontinuing lorazepam, preventing withdrawal symptoms 2.

Special Considerations

Elderly or debilitated patients: Start with diazepam 2-2.5 mg once or twice daily initially, then titrate gradually 1. The conversion ratio remains 1:5, but use lower starting doses.

Renal impairment (eGFR <30): Diazepam is preferred over lorazepam as it undergoes hepatic metabolism rather than renal elimination. No dose adjustment needed for diazepam in renal disease.

Hepatic impairment: Reduce diazepam dose and use with caution, as metabolism is prolonged 1.

Common Pitfalls to Avoid

  • Abrupt switching: Never stop lorazepam and immediately start diazepam at equivalent doses—this can precipitate withdrawal despite "equivalent" dosing 2
  • Overlooking half-life differences: Lorazepam (half-life 12-18 hours) requires BID dosing, while diazepam (half-life 20-100 hours with active metabolites) could theoretically be given once daily, but BID maintains more stable levels during conversion
  • Inadequate monitoring: Watch for withdrawal symptoms (anxiety, tremor, insomnia, agitation) during the first 7-10 days of conversion 1

Monitoring Parameters

During the conversion period, assess for:

  • Withdrawal symptoms: Anxiety, tremor, insomnia, irritability, tachycardia
  • Oversedation: Drowsiness, ataxia, confusion (especially in elderly)
  • Respiratory depression: Particularly if combined with opioids or other CNS depressants 1

The cross-titration method is safer than direct substitution, particularly in patients with chronic benzodiazepine use, elderly patients, or those with cognitive impairment 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.